Krystal Biotech Completes Vyjuvek Pricing Talks In Germany, Italy; Sees Italy Launch In Early 2027
Share
Why It Matters
Krystal Biotech finished price talks for its new medicine in two countries. This means the company is getting closer to selling it there soon.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.